SCHEMBL13264677

SCHEMBL13264677

CNc1ccc(/C=C/c2ccc(N(C)C)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 1/20 0.61
APP P05067 9/20 0.59
MAPT P10636 4/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
CASP1 P29466 2/20 0.57
HBB P68871 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
NPC1 O15118 1/20 0.57
ALOX15 P16050 1/20 0.57
RAB9A P51151 1/20 0.57
GAA P10253 1/20 0.53
BRCA1 P38398 1/20 0.53
CASP7 P55210 1/20 0.53
PTGS1 P23219 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
ALPG P10696 1/20 0.53
THRB P10828 1/20 0.53
HTT P42858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17243614 1.00 RELA (0.61) RELAAPPMAPTMEN1KMT2A
SCHEMBL146321 0.87 ALDH1A1 (0.61) MAPTMEN1KMT2ASMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL9693558 0.84 ALDH1A1 (0.58) MAPTMEN1KMT2AHBBSMN1; SMN2
Hydrochloric Acid SCHEMBL10664947 0.84 ALDH1A1 (0.58) MAPTMEN1KMT2AHBBSMN1; SMN2
SCHEMBL13467434 0.84 RELA (0.81) RELAAPPMAPTMEN1KMT2A
SCHEMBL900823 0.84 APP (0.77) APPKCNH2MAT2A
SCHEMBL7915381 0.84 RELA (0.81) RELAAPPMAPTMEN1KMT2A
SCHEMBL1714446 0.84 RELA (0.81) RELAAPPMAPTMEN1KMT2A
SCHEMBL9680312 0.84 APP (0.77) APPKCNH2MAT2A
SCHEMBL9678907 0.84 APP (0.77) APPKCNH2MAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230201382-A1 RADIOLIGANDS FOR MYELIN NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-06-29 US disclosed
US-7759502-B2 Useful for inhibiting the aggregation of amyloid protein to form amyloid deposit THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-07-20 US disclosed
US-20080108840-A1 Stilbene Derivatives And Their Use For Binding And Imaging Amyloid Plaques TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230201382-A1 RADIOLIGANDS FOR MYELIN MAG, PMP22, MYT1 RELA 4441/4885APP 1514/4885MAPT 2373/4885
US-20080108840-A1 Stilbene Derivatives And Their Use For Binding And Imaging Amyloid Plaques APP, APBA1, PSEN1 RELA 2968/4885APP 1/4885MAPT 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.